Nellcor completes Infrasonics acquisition:
This article was originally published in Clinica
Nellcor Puritan Bennett's purchase of Infrasonics has been completed following shareholder approval. Under the terms of the amended agreement, 0.12 shares of Nellcor will be issued for each unit of Infrasonics stock. Nellcor's shareholders have also approved an increase in the number of authorised shares and a two-for one split of Nellcor stock. Following the split, Nellcor will have about 60 million shares outstanding.
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.